Abstract:Objective:To investigate the antitumor activity and the mechanism of cytokine-induced killer (CIK) cells combined with bevacizumab against hepatocellular carcinoma HepG2 cells in vitro and in vivo.Methods:Peripheral blood mononuclear cells (PBMCs) from healthy blood donors were isolated and cultured in the presence of different cytokines to promote the maturation of CIK cells;and the immune phenotypes of CIK cells were analyzed by flow cytometry.The inhibitory effect on HepG2 cells of CIK cells combining with or without bevacizumab were analyzed by CCK-8 assay.Cell migration and invasion of HepG2 cells were detected by scratch assay and transwell assay.The phosphorylation levels of Erk/Akt signaling pathway related proteins were detected by Western blotting.HepG2 cell xenograft tumor model was established in nude mice.Tumor bearing mice were divided into normal saline control group,CIK group,bevacizumab group and CIK + bevacizumab group.On the 28th day after drug administration,the mice were sacrificed and tumors were isolated.Immunohistochemical staining was used to analyze the expressions of CD31 and Ki67.Results:Human PBMCs were stimulated for 14 days,and the CIK cell phenotype analysis showed that the amplification of CD3 + CD56 + CIK cells reached (36.33 ± 2.58) ％.The inhibition rate of CIK cells combined with bevacizumab was significantly enhanced by comparing with CIK/bevacizumab alone groups (all P ＜ 0.05).CIK cells combined with bevacizumab showed a more intensive inhibition on cell migration([75.6 ±9.53] vs [304.8 ±45.73],[359.8 ±38.10],P ＜0.01) and invasion ([29.35 ± 8.14] ％ vs [55.07 ± 6.27] ％,[60.50 ± 9.73] ％,P ＜ 0.05] by comparing with those two single treatment groups;CIK cell treatment,bevacizumab treatment and the combined treatment could all decrease the phosphorylation level of Erk and Akt;the combined treatment significantly inhibited the tumor growth,mean vessel density (MVD) and Ki67 expression,which had statistical significance when compared with the other groups (P ＜ 0.05).Conclusion:The current study suggested that CIK cells combined with bevacizumab inhibited HepG2 ceils proliferation,invasion and migration both in vitro and in vivo,which significantly precede the treatment efficacy of single treatment groups.

Evaluation of a Modified Culture Method for Immune-Killer Cells and Therapeutic Efficiency on Hepatocarcinoma Cell Line BEL-7402

Cytokine-Induced Killer (cik) Cell Therapy for Patients with Hepatocellular Carcinoma: Efficacy and Safety

Cytokine-induced killer cells in the treatment of patients with solid carcinomas: a systematic review and pooled analysis.

The Anti-Tumor Effects of CIK Cells Combined with Epirubicin Against Hepatocellular Carcinoma

Study on the Effect of IL-12 and IL-15 on the Proliferation of CIK Cells from of Peripheral Blood and the Activity of Killing SMMC-7721 Hepatoma Cell Line in Vitro

Short-term curative efficacy of cytokine-induced killer cells combined micro-invasive treatments on hepatocellular carcinoma]

Cytokine-induced Killer Cells Combined with Dendritic Cells Inhibited Liver Cancer Cells.

Research on Biological Characteristics and Cytotoxicity of CIK Cells in Different Culture Systems

Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study

The Induction of Cytokine-induced Killer and Its Cytotoxic Effect on Hepatic Carcinoma Cells

Expansion and Activation of Natural Killer Cells from PBMC for Immunotherapy of Hepatocellular Carcinoma

Anti-tumor activity of cytokine-induced killer cells combined with bevacizumab against hepatocellular carcinoma HepG2 cells in vitro and in vivo

Co-culture of Dendritic Cells and Cytokine-Induced Killer Cells Effectively Suppresses Liver Cancer Stem Cell Growth by Inhibiting Pathways in the Immune System

Preparation and cytotoxic effects of cytokine-induced killer cells on different tumor cell lines in vitro

Study of Multi-Directional Derivation of Cord Blood Mononuclear Cells and Observation of Killing Activity to MGC-803 Gastric Cancer Cell Strain in Vitro

[Killing Activity in DC and CIK Co-Culture Against Hepatocarcinoma Cells].

Effect of Killer Cell Induced by Cytokines on the Killing Activity to GBC-SD Gallbladder Cancer Cell Strain

In Vitro Anti-Hepatoma Effects of Monocytes and Kupffer Cells Isolated from Hepatoma Patients after Treatment with Biological Immune Stimulants

Influence on Killing Effect of NK Cells in Vitro by Up-Regulation of HLA-E Expression in Hepatocellular Carcinoma Bel7402 Cells

Efficacy of cytokine-induced killer cell-based immunotherapy for hepatocellular carcinoma.

Minimally Invasive Treatment Combined With Cytokine-Induced Killer Cells Therapy Lower The Short-Term Recurrence Rates Of Hepatocellular Carcinomas